- Report
- March 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- May 2024
- 200 Pages
Global
From €3877EUR$4,150USD£3,280GBP
- Report
- January 2024
- 120 Pages
Global
From €5559EUR$5,950USD£4,702GBP
- Report
- June 2023
- 150 Pages
North America
From €4624EUR$4,950USD£3,912GBP
- Report
- June 2022
- 120 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- August 2023
- 97 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- May 2023
- 105 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- June 2022
- 122 Pages
Global
From €1868EUR$2,000USD£1,581GBP
- Report
- April 2025
- 50 Pages
Global
From €2476EUR$2,650USD£2,094GBP
- Report
- April 2025
- 50 Pages
Global
From €2476EUR$2,650USD£2,094GBP
Betamethasone is a corticosteroid drug used to treat a variety of immune disorders, including asthma, allergies, and skin conditions. It works by reducing inflammation and suppressing the immune system. Betamethasone is available in both oral and topical forms, and is often prescribed in combination with other drugs. It is generally well-tolerated, but can cause side effects such as weight gain, increased appetite, and mood swings.
Betamethasone is used to treat a wide range of immune disorders, including asthma, allergies, and skin conditions. It is often prescribed in combination with other drugs, such as antihistamines and antibiotics. Betamethasone is available in both oral and topical forms, and is generally well-tolerated.
Some companies in the Betamethasone market include GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more